Annual Cash & Cash Equivalents
$9.69 M
-$2.14 M-18.10%
December 31, 2023
Summary
- As of February 21, 2025, RXST annual cash & cash equivalents is $9.69 million, with the most recent change of -$2.14 million (-18.10%) on December 31, 2023.
- During the last 3 years, RXST annual cash & cash equivalents has fallen by -$4.30 million (-30.74%).
- RXST annual cash & cash equivalents is now -60.22% below its all-time high of $24.36 million, reached on December 31, 2021.
Performance
RXST Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$16.72 M
-$7.72 M-31.60%
September 30, 2024
Summary
- As of February 21, 2025, RXST quarterly cash and cash equivalents is $16.72 million, with the most recent change of -$7.72 million (-31.60%) on September 30, 2024.
- Over the past year, RXST quarterly cash and cash equivalents has increased by +$7.03 million (+72.51%).
- RXST quarterly cash and cash equivalents is now -75.51% below its all-time high of $68.28 million, reached on September 30, 2021.
Performance
RXST Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RXST Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -18.1% | +72.5% |
| 3 y3 years | -30.7% | +72.5% |
| 5 y5 years | +21.8% | +72.5% |
RXST Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -60.2% | at low | -48.8% | +91.0% |
| 5 y | 5-year | -60.2% | +21.8% | -75.5% | +91.0% |
| alltime | all time | -60.2% | +21.8% | -75.5% | +91.0% |
RxSight Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $16.72 M(-31.6%) |
| Jun 2024 | - | $24.45 M(-25.1%) |
| Mar 2024 | - | $32.65 M(+236.8%) |
| Dec 2023 | $9.69 M(-18.1%) | $9.69 M(-1.7%) |
| Sep 2023 | - | $9.86 M(+12.6%) |
| Jun 2023 | - | $8.75 M(-20.5%) |
| Mar 2023 | - | $11.01 M(-6.9%) |
| Dec 2022 | $11.83 M | $11.83 M(+32.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $8.91 M(-62.9%) |
| Jun 2022 | - | $24.00 M(-0.5%) |
| Mar 2022 | - | $24.13 M(-0.9%) |
| Dec 2021 | $24.36 M(+74.1%) | $24.36 M(-64.3%) |
| Sep 2021 | - | $68.28 M(+63.6%) |
| Jun 2021 | - | $41.73 M(+71.1%) |
| Mar 2021 | - | $24.39 M(+74.3%) |
| Dec 2020 | $13.99 M(+75.8%) | $13.99 M |
| Dec 2019 | $7.96 M | - |
FAQ
- What is RxSight annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for RxSight?
- What is RxSight annual cash & cash equivalents year-on-year change?
- What is RxSight quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for RxSight?
- What is RxSight quarterly cash and cash equivalents year-on-year change?
What is RxSight annual cash & cash equivalents?
The current annual cash & cash equivalents of RXST is $9.69 M
What is the all time high annual cash & cash equivalents for RxSight?
RxSight all-time high annual cash & cash equivalents is $24.36 M
What is RxSight annual cash & cash equivalents year-on-year change?
Over the past year, RXST annual cash & cash equivalents has changed by -$2.14 M (-18.10%)
What is RxSight quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RXST is $16.72 M
What is the all time high quarterly cash and cash equivalents for RxSight?
RxSight all-time high quarterly cash and cash equivalents is $68.28 M
What is RxSight quarterly cash and cash equivalents year-on-year change?
Over the past year, RXST quarterly cash and cash equivalents has changed by +$7.03 M (+72.51%)